AVANOS MEDICAL, INC. Gross Profit

Quick Answer

AVANOS MEDICAL, INC. reported Gross Profit of $353.90 million for the year ending 2025.

  • AVANOS MEDICAL, INC. showed a decrease of -7.2% in Gross Profit from 2024 to 2025.
  • This data is from AVANOS MEDICAL, INC.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
  • XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q3 2013: $161.50 million | Q1 2014: $155.00 million | Q2 2014: $104.90 million | Q3 2014: $132.20 million | Q1 2015: $132.10 million | Q2 2015: $134.90 million | Q3 2015: $131.00 million | Q1 2016: $136.50 million | Q2 2016: $140.70 million | Q3 2016: $138.00 million | Q1 2017: $81.50 million | Q2 2017: $84.50 million | Q3 2017: $81.00 million | Q1 2018: $91.10 million | Q2 2018: $94.70 million | Q3 2018: $104.70 million | Q1 2019: $98.80 million | Q2 2019: $98.70 million | Q3 2019: $95.00 million | Q1 2020: $102.10 million | Q2 2020: $86.50 million | Q3 2020: $95.80 million | Q1 2021: $91.30 million | Q2 2021: $85.70 million | Q3 2021: $90.20 million | Q1 2022: $106.60 million | Q2 2022: $101.60 million | Q3 2022: $100.20 million | Q1 2023: $91.40 million | Q2 2023: $97.80 million | Q3 2023: $95.50 million | Q1 2024: $94.80 million | Q2 2024: $95.60 million | Q3 2024: $92.90 million | Q1 2025: $89.80 million | Q2 2025: $92.10 million | Q3 2025: $86.00 million.
  • Over the full 14 years of available data (2012 to 2025), AVANOS MEDICAL, INC.'s Gross Profit has declined by 41.3%.
  • Historical annual values: Fiscal year 2025: $353.90 million | Fiscal year 2024: $381.30 million | Fiscal year 2023: $379.70 million | Fiscal year 2022: $394.20 million | Fiscal year 2021: $299.20 million | Fiscal year 2020: $370.90 million | Fiscal year 2019: $402.20 million | Fiscal year 2018: $390.90 million | Fiscal year 2017: $336.90 million | Fiscal year 2016: $297.20 million | Fiscal year 2015: $257.80 million | Fiscal year 2014: $548.60 million | Fiscal year 2013: $612.20 million | Fiscal year 2012: $602.50 million.
  • Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: